Evercore ISI downgraded Globe Life from Outperform to In-line and set a new price target of $114.00 from $115.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $114.00 | Market Perform | BMO Capital Markets |
| 1/8/2025 | $132.00 → $143.00 | In-line → Outperform | Evercore ISI |
| 10/9/2024 | $150.00 | Buy | TD Cowen |
| 4/24/2024 | $130.00 → $110.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 10/31/2023 | $122.00 → $137.00 | Equal Weight → Overweight | Wells Fargo |
| 8/18/2023 | $131.00 | Underweight → Equal-Weight | Morgan Stanley |
| 4/25/2023 | $120.00 | Equal Weight | Wells Fargo |
| 10/28/2022 | $115.00 → $114.00 | Outperform → In-line | Evercore ISI |